Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
editorial
. 1991 Sep;64(3):422–424. doi: 10.1038/bjc.1991.325

Coagulation and cancer.

J C Murray
PMCID: PMC1977669  PMID: 1911180

Full text

PDF
422

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clauss M., Murray J. C., Vianna M., de Waal R., Thurston G., Nawroth P., Gerlach H., Bach R., Familletti P. C., Stern D. A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin. J Biol Chem. 1990 Apr 25;265(12):7078–7083. [PubMed] [Google Scholar]
  2. Cozzolino F., Torcia M., Miliani A., Carossino A. M., Giordani R., Cinotti S., Filimberti E., Saccardi R., Bernabei P., Guidi G. Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia. Am J Med. 1988 Feb;84(2):240–250. doi: 10.1016/0002-9343(88)90420-2. [DOI] [PubMed] [Google Scholar]
  3. EISEMAN G., STEFANINI M. Thromboplastic activity of leukemic white cells. Proc Soc Exp Biol Med. 1954 Aug-Sep;86(4):763–765. doi: 10.3181/00379727-86-21226. [DOI] [PubMed] [Google Scholar]
  4. Gordon S. G., Franks J. J., Lewis B. Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thromb Res. 1975 Feb;6(2):127–137. doi: 10.1016/0049-3848(75)90018-3. [DOI] [PubMed] [Google Scholar]
  5. Gralnick H. R., Abrell E. Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukaemia. Br J Haematol. 1973 Jan;24(1):89–99. doi: 10.1111/j.1365-2141.1973.tb05730.x. [DOI] [PubMed] [Google Scholar]
  6. LIEBERMAN J. S., BORRERO J., URDANETA E., WRIGHT I. S. Thrombophlebitis and cancer. JAMA. 1961 Aug 26;177:542–545. doi: 10.1001/jama.1961.03040340006002. [DOI] [PubMed] [Google Scholar]
  7. Mahadevan V., Malik S. T., Meager A., Fiers W., Lewis G. P., Hart I. R. Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown. Cancer Res. 1990 Sep 1;50(17):5537–5542. [PubMed] [Google Scholar]
  8. Murray J. C., Smith K. A., Thurston G. Flavone acetic acid induces a coagulopathy in mice. Br J Cancer. 1989 Nov;60(5):729–733. doi: 10.1038/bjc.1989.348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Nawroth P., Handley D., Matsueda G., De Waal R., Gerlach H., Blohm D., Stern D. Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas. J Exp Med. 1988 Aug 1;168(2):637–647. doi: 10.1084/jem.168.2.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Noguchi M., Sakai T., Kisiel W. Identification and partial purification of a novel tumor-derived protein that induces tissue factor on cultured human endothelial cells. Biochem Biophys Res Commun. 1989 Apr 14;160(1):222–227. doi: 10.1016/0006-291x(89)91644-6. [DOI] [PubMed] [Google Scholar]
  11. Shimomura K., Manda T., Mukumoto S., Kobayashi K., Nakano K., Mori J. Recombinant human tumor necrosis factor-alpha: thrombus formation is a cause of anti-tumor activity. Int J Cancer. 1988 Feb 15;41(2):243–247. doi: 10.1002/ijc.2910410215. [DOI] [PubMed] [Google Scholar]
  12. Sun N. C., McAfee W. M., Hum G. J., Weiner J. M. Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part I. Coagulation studies. Am J Clin Pathol. 1979 Jan;71(1):10–16. doi: 10.1093/ajcp/71.1.10. [DOI] [PubMed] [Google Scholar]
  13. Watanabe N., Niitsu Y., Umeno H., Kuriyama H., Neda H., Yamauchi N., Maeda M., Urushizaki I. Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Res. 1988 Apr 15;48(8):2179–2183. [PubMed] [Google Scholar]
  14. Yudelman I., Greenberg J. Factors affecting fibrinopeptide-A levels in patients with venous thromboembolism during anticoagulant therapy. Blood. 1982 Apr;59(4):787–792. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES